Back to Search Start Over

How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States.

Authors :
Walters SM
Frank D
Felsher M
Jaiswal J
Fletcher S
Bennett AS
Friedman SR
Ouellet LJ
Ompad DC
Jenkins W
Pho MT
Source :
The International journal on drug policy [Int J Drug Policy] 2023 Feb; Vol. 112, pp. 103930. Date of Electronic Publication: 2023 Jan 13.
Publication Year :
2023

Abstract

Background: Hepatitis C virus (HCV) infection has increased among persons who inject drugs (PWID) in the United States with disproportionate burden in rural areas. We use the Risk Environment framework to explore potential economic, physical, social, and political determinants of hepatitis C in rural southern Illinois.<br />Methods: Nineteen in-depth semi-structured interviews were conducted with PWID from August 2019 through February 2020 (i.e., pre-COVID-19 pandemic) and four with key informants who professionally worked with PWID. Interviews were recorded, professionally transcribed, and coded using qualitative software. We followed a grounded theory approach for coding and analyses.<br />Results: We identify economic, physical, policy, and social factors that may influence HCV transmission risk and serve as barriers to HCV care. Economic instability and lack of economic opportunities, a lack of physically available HCV prevention and treatment services, structural stigma such as policies that criminalize drug use, and social stigma emerged in interviews as potential risks for transmission and barriers to care.<br />Conclusion: The rural risk environment framework acknowledges the importance of community and structural factors that influence HCV infection and other disease transmission and care. We find that larger structural factors produce vulnerabilities and reduce access to resources, which negatively impact hepatitis C disease outcomes.<br />Competing Interests: Declarations of Interest The authors declared that they have no conflicts of interest.<br /> (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-4758
Volume :
112
Database :
MEDLINE
Journal :
The International journal on drug policy
Publication Type :
Academic Journal
Accession number :
36641816
Full Text :
https://doi.org/10.1016/j.drugpo.2022.103930